FindTrial
Sign In

Rituximab (MABTHERA® or RITUXAN®).

DRUG2 trials

Sponsors

University Hospital, Toulouse, University Hospital, Ioannina

Conditions

Auto-immune Thrombocytopenic PurpuraCold Agglutinin DiseaseCryoglobulinemiaFocal Segmental Glomerulosclerosis (FSGS)Hemolytic Auto-immune AnaemiaMembranous NephropathyMinimal Change Disease (MCD)Pemphigus

Unknown Phase

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
CompletedNCT00960713
University Hospital, ToulouseAuto-immune Thrombocytopenic Purpura, Cold Agglutinin Disease, Cryoglobulinemia +2
Start: 2009-06-30End: 2012-01-31Updated: 2012-10-23
Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome
CompletedNCT07702981
University Hospital, IoanninaFocal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease (MCD)
Start: 2023-06-01End: 2026-02-01Updated: 2026-07-14